Displaced Greater Tuberosity Fractures With Rotator Cuff Injury

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: Greater Tuberosity Fracture; Rotator Cuff Interventions: Procedure: Arthroscopic surgery Sponsors: Guo Jialiang Not yet recruiting Conditions: Greater Tuberosity Fracture; Rotator Cuff Interventions: Procedure: Arthroscopic surgery Sponsors: Guo Jialiang...

Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: Substrate Metabolism; Healthy Participants; Endurance Exercise Interventions: Other: Carbohydrate-last meal pattern; Other: Carbohydrate-first meal pattern Sponsors: Universidade do Porto; Federação Portuguesa de Futebol; Fundação para a Ciência e a...

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: Esophageal Squamous Cell Carcinoma; High Grade Serous Ovarian Cancer; Head and Neck Squamous Cell Carcinoma; Colorectal Cancer; Castration-resistant Prostate Cancer; Non Small Cell Lung Cancer; Endometrium Cancer; Triple Negative Breast Cancer...

Phase 1 Study of HS-20152 in Healthy Participants

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: Healthy Volunteers Interventions: Drug: HS-20152; Drug: Placebo Sponsors: Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting Conditions: Healthy Volunteers Interventions: Drug: HS-20152; Drug: Placebo Sponsors: Jiangsu Hansoh Pharmaceutical Co.,...

Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: Diabetic Foot Ulcer (DFU); Granulation of Chronic Diabetic Wounds Interventions: Drug: an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous...

A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies

by palligoelme@gmail.com | Mar 31, 2026 | Clinical Trials

​ Conditions: B Cell Malignancies; Acute Lymphobkastic Leukemia; Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) Interventions: Drug: SHB-02-CD19 (anti CD19 CAR-T cells) Sponsors: Sheba Medical Center Not yet recruiting Conditions: B Cell...